Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank0
3Y CAGR-39.2%
5Y CAGR-39.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-39.2%/yr
vs +35.6%/yr prior
5Y CAGR
-39.2%/yr
Consistent
Acceleration
-74.8pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $18.30M | -50.5% |
| 2024 | $37.00M | -72.7% |
| 2023 | $135.70M | +66.8% |
| 2022 | $81.35M | -56.5% |
| 2021 | $186.82M | -15.2% |
| 2020 | $220.38M | +216.8% |
| 2019 | $69.56M | +189.4% |
| 2018 | $24.04M | - |